A randomized, double-blind, placebo-controlled Phase III study of Study Drug versus placebo for patients with advanced gastrointestinal stromal tumors (GIST) who have received prior treatments.
We wrap up the final week of August with news of exciting scientific advancements that have the potential to help develop therapies to prevent…
Inspiration from a Breast Cancer Survivor
Ask the Experts: How Do Blood Cancers Affect Populations Differently?
Blood cancer research has shown improvements in early detection and treatment advancements, which are associated with increased survival. However,…